Arakawa Chemical Industries,ltd.TSE: 4968

Consolidated Financial Results for the Six Months Ended September 30, 2025

· Issued by Arakawa Chemical Industries,ltd.






Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP]

November 5, 2025

Company name: ARAKAWA CHEMICAL INDUSTRIES, LTD.

Stock exchange listing: Tokyo Stock Exchange

Code number: 4968

URL: https://www.arakawachem.co.jp/en/

Representative: Nobuyuki Takagi, Representative Director and President Contact: Toru Nobuhiro, Managing Director and Executive Officer Phone: +81-6-6209-8500

Scheduled date of filing semi-annual securities report: November 12, 2025 Scheduled date of commencing dividend payments: December 1, 2025 Availability of supplementary explanatory materials on financial results: Available

Schedule of financial results briefing session: Scheduled (for institutional investors/securities analysts)

(Amounts of less than one million yen are rounded down.)

  1. Consolidated Financial Results for the Six Months Ended September 30, 2025 (April 1, 2025 - September 30, 2025)
    1. Consolidated Operating Results (% indicates changes from the previous corresponding period.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Six months ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      September 30, 2025

      40,367

      2.6

      929

      196.0

      639

      103.8

      724

      (55.7)

      September 30, 2024

      39,327

      13.4

      313

      -

      313

      -

      1,634

      -

      (Note) Comprehensive income: Six months ended September 30, 2025: ¥ (49) million [-%]

      Six months ended September 30, 2024: ¥ 2,181 million [321.9%]

      Basic earnings per share

      Diluted earnings per share

      Six months ended

      Yen

      Yen

      September 30, 2025

      36.53

      -

      September 30, 2024

      82.41

      -

    2. Consolidated Financial Position

    Total assets

    Net assets

    Equity ratio

    Millions of yen

    Millions of yen

    %

    As of September 30, 2025

    121,261

    56,692

    48.3

    As of March 31, 2025

    122,297

    57,237

    47.8

    (Reference) Equity: As of September 30, 2025: ¥ 58,567 million

    As of March 31, 2025: ¥ 58,475 million

  2. Dividends

    Annual dividends

    1st quarter-end

    2nd quarter-end

    3rd quarter-end

    Year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended

    March 31, 2025

    -

    24.00

    -

    25.00

    49.00

    Fiscal year ending March 31, 2026

    -

    25.00

    Fiscal year ending March 31, 2026

    (Forecast)

    -

    25.00

    50.00

    (Note) Revision to the forecast for dividends announced most recently: None

  3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2026 (April 1, 2025 - March 31,
2026)

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings

per share

Full year

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

85,000

5.9

2,800

164.7

2,400

180,7

1,800

(31.9)

90.73

(Note) Revision to the financial results forecast announced most recently: None

* Notes:
  1. Significant changes in the scope of consolidation during the period under review: None

    Newly included: - companies (Company name) Excluded: - companies (Company name)

  2. Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: None

  3. Changes in accounting policies, changes in accounting estimates and retrospective restatement

    1. Changes in accounting policies due to the revision of accounting standards: None

    2. Changes in accounting policies other than 1) above: None

    3. Changes in accounting estimates: None

    4. Retrospective restatement: None

  4. Total number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares): September 30, 2025: 20,652,400 shares

      March 31, 2025: 20,652,400 shares

    2. Total number of treasury shares at the end of the period: September 30, 2025: 813,671 shares

      March 31, 2025: 813,611 shares

    3. Average number of shares during the period:

Six months ended September 30, 2025: 19,838,774 shares

Six months ended September 30, 2024: 19,838,789 shares

  • These semi-annual consolidated financial results are outside the scope of review by certified public accountants or an audit firm.

  • Explanation on the proper use of financial results forecast and other special notes

Forward-looking statements, including financial results forecasts, contained in this document are based on information currently available to the Company and certain assumptions deemed reasonable. Therefore, these statements do not constitute a guarantee that they will be realized. Actual results may differ materially from these statements due to various factors.

  1. Qualitative Information on Semi-annual Financial Results

    1. Explanation of Operating Results

      During the six months ended September 30, 2025, the Japanese economy continued its modest recovery, supported by improvements in employment and income situation. However, the global economy remains uncertain, with some regions experiencing stagnation, and risks such as US trade policies, China's economic slowdown, increasing geopolitical risks, among others, creating continued uncertainty about prospects.

      In this environment, ARAKAWA CHEMICAL INDUSTRIES, LTD. and its subsidiaries (the "Group") have been pressing forward with key initiatives under "V-ACTION for Sustainability," the 5th Medium-Term Management Plan, now in its final year. In the area of photo-curable resins and fine chemical products-positioned under the "NOBASU" mission-capacity expansions have been completed, and we are steadily progressing toward mass production in response to growing market demand. We are also working to develop new businesses in the life sciences field (healthcare, agriculture, and cosmetics) by leveraging natural materials such as pine and microalgae, with the aim of commercialization. As for hydrogenated hydrocarbon resin, we recognize the stable

      operation of Chiba Arkon Production Limited as an important company-wide challenge, and we have improved its operation rate by strengthening our organizational structure to address this issue, with the "Arkon Special Committee" playing a central role.

      In terms of operating results, sales of photo-curable resins for functional coating chemicals increased,

      surpassing the previous year's period due to the recovery in smartphone shipments, and sales of fine chemicals

      products and polishing agents for hard disk substrates have been maintained record-high levels.

      As a result, for the six months ended September 30, 2025, the Group posted net sales of 40,367 million (up 2.6% year on year), operating profit of 929 million (up 196.0% year on year), ordinary profit of 639 million (up 103.8% year on year), and profit attributable to owners of parent of 724 million (down 55.7% year on year).

      Operating results by segment are as follows. Net sales for each segment do not include inter-segment net sales.

      Functional Coating Chemicals Business

      The electrical and precision equipment related industries are experiencing steady demand, especially for electronic components. In this environment, demand recovery in smartphones and displays led to increased sales of photo-curable resins. Furthermore, thermosetting resins, positioned under the "SODATERU" mission, also saw increased sales through new adoption and expanded sales channels.

      As a result, net sales were ¥8,977 million (up 9.3% year on year), and segment income was ¥1,008 million (up

      68.4% year on year).

      Paper Chemicals & Environmental Business

      Regarding the paper manufacturing industry, paper and paperboard production has continued to fall below the previous year's levels in Japan. In China, amid sluggish demand, production continued to increase, which affected market conditions in other Asian regions and created a challenging situation. Under these conditions, overseas price competition for paper strengthening agents has intensified and resulted in a decline in profits.

      As a result, net sales were 10,094 million (down 8.2% year on year), and segment income was 534 million (down 47.2% year on year).

      Adhesive & Biomass Materials Business

      In the adhesives industry, concerns exist that demand may decline in the automobile-related field due to the uncertainty surrounding U.S. tariff policies, resulting in weak demand for those used for tapes and sheets, etc. In this environment, sales of rosin tackifier for adhesives remained stable, particularly in the Asian region. Regarding hydrogenated hydrocarbon resins, Chiba Arkon Production Limited improved its operation rate and has begun stable supply to Europe.

      As a result, net sales were 13,890 million (up 5.0% year on year), and segment loss was 603 million (segment loss of 1,292 million in the same period of the previous year).

      Fine Chemicals & Electronics Business

      In the electronics industry, demand for electronic components, etc., is recovering, and investment in data centers, associated with increased demand for generative AI, is growing steadily. In this environment, sales of polishing agents for hard disk substrates used in data centers and fine chemical products for semiconductor-related advanced materials increased. Regarding polishing agents and compounded products for electronic material, we are progressively implementing price revisions, but cost increases are currently outpacing sales prices. Regarding newly enhanced production capacity for semiconductor-related advanced materials, depreciation has been recorded since May 2025, and mass production is scheduled to begin in the latter half of the next fiscal year after obtaining customer approvals.

      As a result, net sales were ¥7,366 million (up 7.6% year on year), and segment income was ¥274 million (down

      25.4% year on year).

    2. Explanation of Financial Position

      1. Overview of Assets and Liabilities

        Total assets as of September 30, 2025, decreased by ¥1,036 million compared to the end of the previous consolidated fiscal year, totaling ¥121,261 million. The main reasons include a decrease of ¥889 million in inventories and a decrease of ¥1,192 million in property, plant and equipment, despite an increase of 1,301 million in investment securities.

        Liabilities decreased by ¥491 million compared to the end of the previous consolidated fiscal year, reaching

        ¥64,568 million. This was despite a 2,163 million increase in short-term borrowings, mainly attributable to decreases in notes and accounts payable-trade of ¥1,280 million and long-term borrowings of ¥1,406 million.

        Total net assets decreased by ¥545 million compared to the end of the previous consolidated fiscal year to

        ¥56,692 million, mainly due to decreases in foreign currency translation adjustment, despite increases in

        retained earnings and valuation difference on available-for-sale securities.

      2. Overview of Cash Flows

      Cash and cash equivalents at the end of the period under review increased by 932 million from the end of the previous fiscal year to 7,367 million.

      Net cash provided by operating activities increased by ¥1,249 million. This was due to net income before income taxes (¥667 million) and depreciation (¥2,710 million), among other factors.

      Net cash used in investing activities decreased by ¥622 million. This resulted from a decrease in cash mainly due to the purchase of property, plant and equipment and intangible assets (¥1,904 million), among other factors, despite an increase in cash from the decrease in time deposits (¥1,302 million).

      Net cash provided by financing activities increased by ¥324 million. This was due to an increase in cash resulting from a net increase in borrowings (826 million), among other factors, despite a decrease in cash due to dividend payments (¥495 million), among other factors.

    3. Forward-looking Statements such as Earnings Forecasts

      There are no revisions to the full-year consolidated earnings forecast disclosed on May 14, 2025. (Reference) Depreciation recognized at Chiba Arkon Production Limited

      (Millions of yen)

      FY 2022

      FY 2023

      FY 2024

      FY 2025 (forecast)

      FY 2026 (forecast)

      1,043

      2,315

      1,954

      Approx. 1,600

      Approx. 1,400

      The forward-looking statements regarding performance forecasts and other future projections contained in this document are based on the information currently available to our company and on certain assumptions deemed reasonable. However, these statements are not promises or guarantees of future performance by the company.

      Actual results may differ significantly due to various factors.

  2. Semi-annual Consolidated Financial Statements and Principal Notes

  1. Semi-annual Consolidated Balance Sheets

    (Millions of yen)

    As of March 31, 2025 As of September 30, 2025

    Assets

    Current assets

    Cash and deposits

    9,431

    9,074

    Notes and accounts receivable - trade

    25,884

    25,778

    Electronically recorded monetary claims -

    operating

    2,258

    2,241

    Merchandise and finished goods

    12,619

    11,798

    Work in process

    1,468

    1,439

    Raw materials and supplies

    9,730

    9,692

    Other

    997

    1,432

    Allowance for doubtful accounts

    (126)

    (115)

    Total current assets

    62,264

    61,341

    Non-current assets

    Property, plant and equipment

    Buildings and structures, net

    18,604

    18,134

    Machinery, equipment and vehicles, net

    13,487

    12,303

    Land

    5,008

    5,003

    Construction in progress

    846

    1,346

    Other, net

    1,092

    1,059

    Total property, plant and equipment

    39,039

    37,847

    Intangible assets

    1,374

    1,180

    Investments and other assets

    Investment securities

    10,105

    11,407

    Retirement benefit asset

    7,392

    7,585

    Deferred tax assets

    288

    237

    Other

    386

    409

    Allowance for doubtful accounts

    (86)

    (80)

    Total investments and other assets

    18,086

    19,559

    Total non-current assets

    58,500

    58,587

    Deferred assets

    Business commencement expenses

    1,532

    1,331

    Total deferred assets

    1,532

    1,331

    Total assets

    122,297

    121,261

    Liabilities

    Current liabilities

    Notes and accounts payable - trade

    9,200

    7,920

    Electronically recorded obligations - operating

    1,172

    1,057

    Short-term borrowings

    18,319

    20,482

    Income taxes payable

    774

    370

    Accrued consumption taxes

    52

    238

    Provision for bonuses

    1,370

    1,246

    Provision for bonuses for directors (and other

    officers)

    27

    10

    Provision for repairs

    820

    525

    Provision for loss on business liquidation

    56

    57

    Asset retirement obligations

    26

    -

    Notes payable - facilities

    104

    132

    Other

    5,682

    5,910

    Total current liabilities

    37,608

    37,953

    Non-current liabilities

    Bonds payable

    10,000

    10,000

    Long-term borrowings

    11,061

    9,654

    Deferred tax liabilities

    4,161

    4,742

    Retirement benefit liability

    259

    270

    Asset retirement obligations

    1,832

    1,829

    Other

    135

    117

    Total non-current liabilities

    27,451

    26,615

    Total liabilities

    65,060

    64,568

    Net assets

    Shareholders' equity

    Share capital

    3,343

    3,343

    Capital surplus

    3,564

    3,564

    Retained earnings

    40,619

    40,848

    Treasury shares

    (1,211)

    (1,211)

    Total shareholders' equity

    46,315

    46,544

    Accumulated other comprehensive income

    Valuation difference on available-for-sale

    securities

    4,384

    5,291

    Foreign currency translation adjustment

    4,671

    3,819

    Remeasurements of defined benefit plans

    3,103

    2,911

    Total accumulated other comprehensive income

    12,159

    12,022

    Non-controlling interests

    (1,237)

    (1,874)

    Total net assets

    57,237

    56,692

    Total liabilities and net assets

    122,297

    121,261

    (Millions of yen) As of March 31, 2025 As of September 30, 2025

  2. Semi-annual Consolidated Statements of Income and Comprehensive Income Semi-annual Consolidated Statements of Income

    (Millions of yen)

    For the six months ended September 30, 2024

    For the six months ended September 30, 2025

    Net sales

    39,327

    40,367

    Cost of sales

    31,568

    31,855

    Gross profit

    7,759

    8,511

    Selling, general and administrative expenses

    7,445

    7,582

    Operating profit (loss)

    313

    929

    Non-operating income

    Interest income

    55

    49

    Dividend income

    114

    146

    Rental income from real estate

    27

    28

    Foreign exchange gains

    137

    -

    Other

    91

    125

    Total non-operating income

    427

    350

    Non-operating expenses

    Interest expenses

    189

    236

    Foreign exchange losses

    -

    153

    Amortization of business commencement expenses

    198

    198

    Other

    39

    51

    Total non-operating expenses

    427

    640

    Ordinary profit (loss)

    313

    639

    Extraordinary income

    Gain on sale of non-current assets

    984

    0

    Gain on sale of investment securities

    314

    121

    Total extraordinary income

    1,299

    121

    Extraordinary losses

    Loss on sale and retirement of non-current assets

    45

    93

    Total extraordinary losses

    45

    93

    Profit (loss) before income taxes

    1,566

    667

    Income taxes - current

    673

    374

    Income taxes - deferred

    156

    301

    Total income taxes

    830

    675

    Profit (loss)

    736

    (8)

    Profit (loss) attributable to non-controlling interests

    (898)

    (732)

    Profit (loss) attributable to owners of parent

    1,634

    724

    Semi-annual Consolidated Statements of Comprehensive Income

    (Millions of yen)

    For the six months ended September 30, 2024

    For the six months ended September 30, 2025

    Profit (loss)

    736

    (8)

    Other comprehensive income

    Valuation difference on available-for-sale securities

    (101)

    907

    Foreign currency translation adjustment

    1,706

    (754)

    Remeasurements of defined benefit plans, net of tax

    (160)

    (193)

    Total other comprehensive income

    1,444

    (40)

    Comprehensive income

    2,181

    (49)

    Comprehensive income attributable to

    Comprehensive income attributable to owners of parent

    2,914

    587

    Comprehensive income attributable to non-controlling

    interests

    (732)

    (637)

  3. Semi-annual Consolidated Statements of Cash Flows

    (Millions of yen)

    For the six months ended

    For the six months ended

    September 30, 2024

    September 30, 2025

    Cash flows from operating activities

    Profit (loss) before income taxes

    1,566

    667

    Depreciation

    2,709

    2,710

    Amortization of business commencement expenses

    198

    198

    Increase (decrease) in allowance for doubtful accounts

    2

    (9)

    Increase (decrease) in provision for bonuses

    (25)

    (115)

    Increase (decrease) in provision for bonuses for directors (and other officers)

    10

    (17)

    Increase (decrease) in retirement benefit liability

    (0)

    10

    Decrease (increase) in retirement benefit asset

    (167)

    (189)

    Increase (decrease) in provision for loss on business liquidation

    (40)

    -

    Loss (gain) on sale and retirement of non-current assets

    (938)

    93

    Loss (gain) on sale of investment securities

    (314)

    (121)

    Interest and dividend income

    (170)

    (196)

    Interest expenses

    189

    236

    Decrease (increase) in trade receivables

    1,615

    (262)

    Decrease (increase) in inventories

    1,715

    677

    Increase (decrease) in trade payables

    (1,884)

    (1,241)

    Increase (decrease) in accrued consumption taxes

    307

    320

    Other, net

    (939)

    (707)

    Subtotal

    3,833

    2,055

    Interest and dividends received

    176

    200

    Interest paid

    (177)

    (215)

    Income taxes refund (paid)

    (434)

    (790)

    Net cash provided by (used in) operating activities

    3,398

    1,249

    Cash flows from investing activities

    Decrease (increase) in time deposits

    393

    1,302

    Purchase of property, plant and equipment

    (1,806)

    (1,886)

    Proceeds from sale of property, plant and equipment

    769

    0

    Purchase of investment securities

    (19)

    (21)

    Proceeds from sale of investment securities

    355

    155

    Purchase of intangible assets

    (58)

    (18)

    Decrease (increase) in investments and other assets

    (8)

    (26)

    Other, net

    (34)

    (128)

    Net cash provided by (used in) investing activities

    (407)

    (622)

    (Millions of yen)

    For the six months ended

    For the six months ended

    September 30, 2024

    September 30, 2025

    Cash flows from financing activities

    Net increase (decrease) in short-term borrowings

    (1,126)

    2,231

    Repayments of long-term borrowings

    (1,652)

    (1,405)

    Purchase of treasury shares

    -

    (0)

    Dividends paid

    (476)

    (495)

    Other, net

    (8)

    (6)

    Net cash provided by (used in) financing activities

    (3,264)

    324

    Effect of exchange rate change on cash and cash equivalents

    361

    (19)

    Net increase (decrease) in cash and cash equivalents

    88

    932

    Cash and cash equivalents at beginning of period

    9,164

    6,434

    Cash and cash equivalents at end of period

    9,253

    7,367

  4. Notes to Semi-annual Consolidated Financial Statements

(Segment information, etc.) [Segment information]

For the six months ended September 30, 2024 (from April 1, 2024 to September 30, 2024)

  1. Information on net sales and income or loss by reportable segment

    (Millions of yen)

    Reportable segments

    Others (Note)

    Total

    Functional Coating Chemicals

    Paper Chemicals & Environmental

    Business

    Adhesive & Biomass Materials

    Fine Chemicals & Electronics

    Total

    Net sales

    Net sales to external customers

    8,211

    10,993

    13,230

    6,843

    39,280

    47

    39,327

    Inter-segment sales or transfers

    -

    -

    -

    -

    -

    14

    14

    Total

    8,211

    10,993

    13,230

    6,843

    39,280

    62

    39,342

    Segment income (loss)

    599

    1,011

    (1,292)

    367

    685

    28

    714

    Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.

  2. Reconciliation of total income or loss of reportable segments with the amount reported in the semi-annual consolidated statements of income and main components of the difference (matters related to adjustments)

    (Millions of yen)

    Income

    Amount

    Total of reportable segments

    685

    Income in "Others" category

    28

    Variance from the allocation of corporate expenses (Note 1)

    (4)

    Corporate research and development expenses (Note 2)

    (188)

    Non-operating income and expenses (Note 3)

    (207)

    Operating loss in the semi-annual consolidated statements of income

    313

    Notes: 1. The variance from the allocation of corporate expenses primarily represents the difference in the estimated allocation of general and administrative expenses to reportable segments.

    1. Corporate research and development expenses represent new research and development costs not allocated to reportable segments, which are the source of medium- to long-term growth.

    2. Non-operating income and expenses primarily consist of items recorded as non-operating income and expenses in reportable segments.

  3. Information on impairment losses on non-current assets or goodwill, etc., by reportable segment Not applicable

For the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)

  1. Information on net sales and income or loss by reportable segment

    (Millions of yen)

    Reportable segments

    Others (Note)

    Total

    Functional Coating Chemicals

    Paper Chemicals & Environmental Business

    Adhesive & Biomass Materials

    Fine Chemicals & Electronics

    Total

    Net sales

    Net sales to external customers

    8,977

    10,094

    13,890

    7,366

    40,330

    37

    40,367

    Inter-segment sales or transfers

    -

    -

    -

    -

    -

    21

    21

    Total

    8,977

    10,094

    13,890

    7,366

    40,330

    58

    40,389

    Segment income (loss)

    1,008

    534

    (603)

    274

    1,213

    16

    1,230

    Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.

  2. Reconciliation of total income or loss of reportable segments with the amount reported in the semi-annual consolidated statements of income and main components of the difference (matters related to adjustments)

    (Millions of yen)

    Income

    Amount

    Total of reportable segments

    1,213

    Income in "Others" category

    16

    Variance from the allocation of corporate expenses (Note 1)

    (45)

    Corporate research and development expenses (Note 2)

    (247)

    Non-operating income and expenses (Note 3)

    (9)

    Operating profit in the semi-annual consolidated statements of income

    929

    Notes: 1. The variance from the allocation of corporate expenses primarily represents the difference in the estimated allocation of general and administrative expenses to reportable segments.

    1. Corporate research and development expenses represent new research and development costs and new business development costs not allocated to reportable segments, which are the source of medium- to long-term growth.

    2. Non-operating income and expenses primarily consist of items recorded as non-operating income and expenses in reportable segments.

  3. Information on impairment losses on non-current assets or goodwill, etc., by reportable segment Not applicable

(Revenue recognition)

Disaggregation of revenue from contracts with customers

For the six months ended September 30, 2024 (from April 1, 2024 to September 30, 2024)

(Millions of yen)

Reportable segments

Others (Note)

Total

Functional Coating Chemicals

Paper Chemicals & Environmental Business

Adhesive & Biomass Materials

Fine Chemicals & Electronics

Total

Net sales

Japan

6,623

6,012

5,449

4,341

22,426

47

22,474

China

983

1,972

3,751

1,114

7,820

-

7,820

Asia

(excluding China)

551

2,998

2,109

1,289

6,948

-

6,948

South and North America, Europe, Others

53

11

1,921

98

2,084

-

2,084

Revenue from contracts with customers

8,211

10,993

13,230

6,843

39,280

47

39,327

Net sales to external customers

8,211

10,993

13,230

6,843

39,280

47

39,327

Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.

For the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025)

(Millions of yen)

Reportable segments

Others (Note)

Total

Functional Coating Chemicals

Paper Chemicals & Environmental

Business

Adhesive & Biomass Materials

Fine Chemicals & Electronics

Total

Net sales

Japan

7,137

5,733

5,627

4,967

23,465

37

23,502

China

1,163

1,610

4,499

1,110

8,384

-

8,384

Asia

(excluding China)

640

2,747

1,954

1,234

6,577

-

6,577

South and North America, Europe, Others

36

3

1,809

54

1,903

-

1,903

Revenue from contracts with customers

8,977

10,094

13,890

7,366

40,330

37

40,367

Net sales to external customers

8,977

10,094

13,890

7,366

40,330

37

40,367

Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.

Earlier from Arakawa Chemical Industries,ltd

All Arakawa Chemical Industries,ltd news releases